Triplet Therapy, Transplantation, and Maintenance until Progression in MyelomaPaul G. Richardson, Irene M. Ghobrial, Edward N. Libby et al.|New England Journal of Medicine|2022Cited by 457
High-dose anakinra to treat refractory immune effector cell-associated neurotoxicity syndrome in CAR T-cell therapy recipientsEmily C. Liang, Richard T. Maziarz, Smith Kungwankiattichai et al.|Blood|2025Cited by 0
Comprehensive Benchmarking of Outcomes after Anakinra Treatment for Refractory Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS)Smith Kungwankiattichai, Jordan Gauthier, Emily C. Liang et al.|Transplantation and Cellular Therapy|2026Cited by 0
Early neurologic response predicts outcomes after anakinra for immune effector cell–associated neurotoxicity syndromeEmily C. Liang, Jordan Gauthier, Smith Kungwankiattichai et al.|Blood Advances|2026Cited by 0